Novartis Venture Fund
Basel, Switzerland · Seed → Growth
Their stated focus (public profile)
The Novartis Venture Fund invests in innovative biotechnology and biopharmaceutical life science companies across North America and Europe, with a focus on novel therapeutics and platforms addressing unmet patient needs. The fund manages over USD 750 million in committed capital across more than 40 portfolio companies, taking an active, hands-on board role. It primarily targets Seed and Series A stage companies, while remaining open to later-stage opportunities.
Stages: Seed → Growth
Sectors: Life sciences
Check size: USD 5-10 million, up to USD 25 million per company
On file: 11 partners on record · 31 companies on record
Website: nvfund.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.